Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KRT6A antibody (CF®647)

This anti-KRT6A antibody is a Mouse Monoclonal antibody detecting KRT6A in IHC, FACS and IHC (fp). Suitable for Human.
Catalog No. ABIN7656204

Quick Overview for KRT6A antibody (CF®647) (ABIN7656204)

Target

See all KRT6A Antibodies
KRT6A (Keratin 6A (KRT6A))

Reactivity

  • 85
  • 21
  • 14
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 66
  • 33
  • 2
Mouse

Clonality

  • 63
  • 38
Monoclonal

Conjugate

  • 49
  • 15
  • 9
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KRT6A antibody is conjugated to CF®647

Application

  • 59
  • 54
  • 36
  • 19
  • 16
  • 12
  • 11
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

KRT6A-2368
  • Purpose

    Cytokeratin 6A (KRT6A) (Basal Cell Marker) (KRT6A/2368), CF647 conjugate

    Characteristics

    This MAb recognizes a protein of 56 kDa, identified as cytokeratin 6A (KRT6A). In humans, multiple isoforms of Cytokeratin 6 (6A-6F), encoded by several highly homologous genes, have distinct tissue expression patterns. Cytokeratin 6A is the dominant form in epithelial tissue. Cytokeratin 6 and 16 are expressed in keratinocytes, which are undergoing rapid turnover in the suprabasal region (also known as hyper-proliferation-related keratins). Cytokeratin 6 is found in hair follicles, suprabasal cells of a variety of internal stratified epithelia, in epidermis, in both normal and hyper-proliferative situations. Epidermal injury results in activation of keratinocytes, which express KRT6 and KRT16. KRT6 is strongly expressed in about 75 % of head and neck squamous cell carcinomas. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant full-length human Cytokeratin 6A (KRT6A) protein

    Isotype

    IgG2a, kappa
  • Application Notes

    Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody. Immunohistology (formalin): 1-2 μg/mL for 30 minutes at RT. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 minutes followed by cooling at RT for 20 minutes. Optimal dilution for a specific application should be determined by user

    Comment

    Positive Control: Tonsil or Basal Cell Carcinoma (BCC)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    KRT6A (Keratin 6A (KRT6A))

    Alternative Name

    Keratin 6A

    Background

    Synonyms: 58 kDa Cytokeratin, CK5, Cytokeratin-5, DDD1, Epidermolysis Bullosa Simplex 2 (EBS2), Keratin 5, Keratin, Type II Cytoskeletal 5, Keratin-5, KRT5, Type-II Cytoskeletal 5, Type-II keratin Kb5

    Gene Symbol: KRT6A

    Tissue Expression: Epidermal cells

    Molecular Weight

    56 kDa

    Gene ID

    3853

    UniProt

    P02538
You are here:
Chat with us!